ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.68 Cr | ₹4.62 Cr | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹4.68 Cr |
| Mar2025 | ₹4.62 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹1.96 Cr |
| Mar2022 | ₹1.63 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.68 Cr | 1.36 | |
| Mar2025 | ₹4.62 Cr | 2.17 | |
| Mar2024 | ₹4.52 Cr | 130.38 | |
| Mar2023 | ₹1.96 Cr | 20.22 | |
| Mar2022 | ₹1.63 Cr | - | |
Compare Contingent Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹460.4 Cr | 0.8% | 16.7% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 0.8% |
16.7% |
-4.7% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses